In addition to ChestEye™, Oxipit has expanded its product portfolio with other groundbreaking solutions. Among them is SliceMap™, an AI-powered tool that revolutionizes the analysis of CT scans. By providing radiologists with a comprehensive visualization of CT slices in a 3D manner, SliceMap™ enables faster and more accurate detection of abnormalities, such as tumors, aneurysms, and vascular malformations.

This breakthrough technology allows for enhanced precision and efficiency in diagnosis, ultimately leading to better patient outcomes.

Oxipit's commitment to innovation doesn't end with its existing product line. The company continues to invest in research and development to tackle new challenges in medical imaging. With a dedicated team of experts and partnerships with leading medical institutions, Oxipit is at the forefront of AI-driven advancements in the field. Their relentless pursuit of excellence and desire to improve patient care is positioning Oxipit as a frontrunner in the global healthcare industry.

As the demand for AI-powered medical imaging solutions grows, Oxipit is rapidly expanding its presence in international markets. The company has successfully deployed its technologies in various healthcare facilities worldwide, gaining recognition and acclaim for their transformative impact on diagnostic processes.

Radiologists and healthcare professionals are embracing Oxipit's solutions for their ability to enhance accuracy, streamline workflows, and improve patient outcomes. The company's relentless pursuit of excellence, coupled with its commitment to improving patient care, positions Oxipit as a key player in the ongoing digital transformation of the healthcare industry.